Optimer Pharmaceuticals Inc (NASDAQ:OPTR.DL)

CAPS Rating: No stars

A biopharmaceutical company focused on discovering, developing and commercializing innovative anti-infective products.

OPTR.DL News and Commentary

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top OPTR.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

mamastox (23.09)
Submitted May 28, 2011

FDA approval for Dificid to treat gram positive( C-diff) bacteria, a potentially deadly superbug which causes,clostridium difficile associated diarreah. (CDAD ). This is an alternative drug to Vancomycin which has been the main antibiotic to treat… More

zzlangerhans (99.82)
Submitted March 02, 2013

Optimer stock is weathering yet another quarter of disappointing Dificid revenues by floating the old "strategic alternatives" flag. Sometimes the sale happens, more often that not it doesn't. I remember that tactic didn't work out very well for… More

OPTR.DL VS S&P 500 (SPY)

OPTR.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about OPTR.DL.

No one has written a Pitch for OPTR.DL stock yet. Tell us why you think OPTR.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in OPTR.DL.

No players have picked OPTR.DL yet. Tell us why you think OPTR.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackBofASec 96.04 9/19/2012 Underperform NS $14.74 -13.30% +18.92% +32.22 10/24/2013 @ $12.78 0 Comment
TrackSunTrustRH 89.13 6/15/2012 Outperform NS $15.20 -15.92% +30.88% -46.80 10/24/2013 @ $12.78 0 Comment
TrackZacks < 20 5/11/2012 Outperform 3M $15.04 -39.83% +1.88% -41.71 11/9/2012 @ $9.05 1 Comment
TrackPoisedTo < 20 4/10/2012 Underperform 5Y $13.04 -1.99% +26.55% +28.54 10/24/2013 @ $12.78 0 Comment
TrackJimCramer 84.63 2/10/2012 Outperform 3W $13.54 -5.61% +29.93% -35.54 10/24/2013 @ $12.78 0 Comment
TrackBreanMurray 77.79 9/21/2011 Outperform NS $16.15 -20.87% +45.20% -66.06 10/24/2013 @ $12.78 0 Comment
TrackZacks < 20 8/9/2011 Outperform 3M $7.52 +59.04% +3.63% +55.42 12/14/2011 @ $11.96 1 Comment
TrackRWBaird 91.41 12/1/2010 Outperform NS $10.08 +29.46% +35.60% -6.13 5/10/2013 @ $13.05 0 Comment
TrackJMP 84.37 11/22/2010 Outperform NS $9.58 +33.40% +46.10% -12.70 10/24/2013 @ $12.78 0 Comment
TrackLadenburg < 20 1/22/2010 Outperform NS $13.30 -3.91% +56.99% -60.90 10/24/2013 @ $12.78 0 Comment
TrackOppenheimer 70.45 11/13/2009 Outperform NS $12.45 -13.65% +31.37% -45.03 10/9/2012 @ $10.75 0 Comment
TrackNeedham 91.25 7/29/2009 Outperform NS $14.91 -20.99% +36.68% -57.68 3/31/2011 @ $11.78 0 Comment
TrackLadenburg < 20 5/20/2009 Outperform NS $12.18 -1.89% +16.34% -18.23 11/4/2009 @ $11.95 0 Comment
TrackLadenburg < 20 2/23/2009 Outperform NS $10.70 0% +15.15% -15.15 5/18/2009 @ $10.70 0 Comment
trackthinkequity 90.58 2/20/2009 Outperform NS $10.83 +18.01% +127.51% -109.51 10/24/2013 @ $12.78 0 Comment
TrackOppenheimer 70.45 12/18/2008 Outperform NS $8.98 +34.74% +16.14% +18.61 11/4/2009 @ $12.10 0 Comment
TrackRWBaird 91.41 11/11/2008 Outperform NS $7.88 +81.22% +9.85% +71.37 7/30/2009 @ $14.28 0 Comment
TrackNeedham 91.25 7/1/2008 Outperform NS $8.02 +27.31% -28.90% +56.20 5/18/2009 @ $10.21 0 Comment
TrackRodmanRen < 20 3/27/2008 Outperform NS $6.50 +96.62% +30.08% +66.53 10/24/2013 @ $12.78 0 Comment
TrackCanaccord 63.14 1/31/2008 Outperform NS $6.70 +88.52% +24.47% +64.05 7/31/2013 @ $12.63 0 Comment
TrackJMP 84.37 3/21/2007 Outperform NS $10.25 -0.39% -36.16% +35.77 5/18/2009 @ $10.21 0 Comment
TrackJefferies 85.72 3/21/2007 Outperform NS $10.74 +18.99% +23.72% -4.73 10/24/2013 @ $12.78 0 Comment

Featured Broker Partners